Scarica l'app Stockscreener
47.35
0.61%
0.34
Precedente Chiudi:
$47.01
Aprire:
$47
Volume 24 ore:
134.02K
Relative Volume:
0.26
Capitalizzazione di mercato:
$1.50B
Reddito:
$566.77M
Utile/perdita netta:
$48.16M
Rapporto P/E:
39.79
EPS:
1.19
Flusso di cassa netto:
$274.29M
1 W Prestazione:
+0.84%
1M Prestazione:
-3.16%
6M Prestazione:
+49.48%
1 anno Prestazione:
+45.30%
Intervallo 1D:
$46.50
$48.29
Intervallo di 1 settimana:
$44.43
$48.29
Portata 52W:
$23.23
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Nome
Collegium Pharmaceutical Inc
Settore
Telefono
781-713-3699
Indirizzo
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Confronta COLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
47.30 | 1.49B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
123.91 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.98 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.64 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
470.67 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-01-10 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-05-10 | Downgrade | Needham | Buy → Hold |
| 2024-05-10 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-25 | Reiterato | Needham | Buy |
| 2023-05-02 | Ripresa | Jefferies | Buy |
| 2022-08-08 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-14 | Iniziato | BWS Financial | Sell |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-02-19 | Ripresa | Jefferies | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-03 | Ripresa | H.C. Wainwright | Buy |
| 2019-04-12 | Ripresa | Janney | Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-02-07 | Reiterato | Needham | Buy |
| 2017-12-05 | Reiterato | Needham | Buy |
| 2017-09-11 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-09-13 | Iniziato | Gabelli & Co | Buy |
| 2015-06-01 | Iniziato | Jefferies | Buy |
| 2015-06-01 | Iniziato | Needham | Buy |
| 2015-06-01 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
Collegium Pharmaceutical, Inc. $COLL Shares Sold by Emerald Advisers LLC - MarketBeat
Collegium Pharmaceutical: Buying The Projected Growth For 2026 - Seeking Alpha
(COLL) Risk Channels and Responsive Allocation - Stock Traders Daily
Campbell & CO Investment Adviser LLC Cuts Stock Position in Collegium Pharmaceutical, Inc. $COLL - Defense World
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pullback - simplywall.st
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Swings - Yahoo Finance
Is It Too Late To Consider Collegium Pharmaceutical (COLL) After A 40% One Year Gain? - simplywall.st
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference - GlobeNewswire
Does Collegium’s 2026 Revenue Guidance After Insider Sales Change The Bull Case For COLL? - simplywall.st
Eastern Bank Buys 45,508 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025 - AOL.com
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? - Yahoo Finance
Q4 Earnings Estimate for COLL Issued By HC Wainwright - Defense World
Best value stocks to buy for Dec. 18 - MSN
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Needham & Company LLC Forecasts Strong Price Appreciation for Collegium Pharmaceutical (NASDAQ:COLL) Stock - Defense World
Will Authorized Generic Nucynta Launch and New Credit Facility Change Collegium Pharmaceutical's (COLL) Narrative? - Yahoo Finance
(COLL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Can Collegium Pharmaceutical Inc. stock outperform in 2025 bull marketRisk Management & Accurate Trade Setup Notifications - Улправда
Will Collegium Pharmaceutical Inc. stock benefit from commodity pricesMarket Trend Report & AI Powered Buy/Sell Recommendations - ulpravda.ru
Is It Time To Reassess Collegium Pharmaceutical (COLL) After Its Strong Five Year Share Price Run? - Yahoo Finance
How Collegium Pharmaceutical Inc. stock performs in weak economyMarket Trend Review & Free Accurate Trade Setup Notifications - ulpravda.ru
Is Collegium Pharmaceutical Inc. stock positioned for digital transformationMarket Weekly Review & Long Hold Capital Preservation Plans - Улправда
A Look At Collegium Pharmaceutical (COLL) Valuation After 2026 Guidance And Nucynta Authorized Generic Agreements - simplywall.st
Collegium Pharmaceutical (NASDAQ:COLL) Trading Down 6.8% on Analyst Downgrade - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Price Target Cut to $56.00 by Analysts at Barclays - MarketBeat
How Good Is Collegium Pharmaceutical, Inc. (NASDAQ:COLL), When It Comes To ROE? - 富途牛牛
Collegium Pharmaceutical (NASDAQ:COLL) Price Target Raised to $56.00 - MarketBeat
Truist Financial Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $55 - 富途资讯
COLL FinancialsIncome Statement - Quiver Quantitative
What 6 Analyst Ratings Have To Say About Collegium Pharmaceutical - Benzinga
Collegium Pharmaceutical (NASDAQ:COLL) Cut to “Hold” at Zacks Research - Defense World
Can Collegium Pharmaceutical Inc. stock sustain free cash flow growthJuly 2025 Retail & Daily Growth Stock Tips - Улправда
Collegium Provides 2026 Financial Guidance and Business Update - Sahm
How Collegium’s New $980 Million Credit Facility Could Reshape Collegium Pharmaceutical (COLL) Investors’ Risk Lens - Sahm
Collegium Pharmaceutical issues 2026 revenue guidance in line with estimates - MSN
Is Collegium Pharmaceutical Inc. stock trading at a premium valuationQuarterly Trade Summary & Consistent Return Strategy Ideas - Улправда
How Collegium Pharmaceutical Inc. (354) stock reacts to monetary easingJuly 2025 Setups & Advanced Technical Signal Analysis - Улправда
Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Raises Target Price to $56 - 富途牛牛
Is Collegium Pharmaceutical Inc. (354) stock a top dividend aristocrat candidate2025 Big Picture & Consistent Growth Stock Picks - ulpravda.ru
Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spendingMarket Risk Report & Real-Time Chart Pattern Alerts - ulpravda.ru
How geopolitical tensions affect Collegium Pharmaceutical Inc. stockEarnings Miss & AI Optimized Trading Strategy Guides - ulpravda.ru
Collegium Pharmaceutical, Inc. Provides Earnings Guidance for Full Year 2026 - marketscreener.com
Collegium Pharmaceutical, Inc. Announces 2026 Financial Guidance - TradingView — Track All Markets
Star TribuneCollegium Provides 2026 Financial Guidance and Business Update - FinancialContent
Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Royalty Pharma (NASDAQ:RPRX) - TradingView — Track All Markets
Truist Securities Adjusts Price Target on Collegium Pharmaceutical to $55 From $48, Maintains Buy Rating - marketscreener.com
Is Collegium Pharmaceutical Inc a good long term investmentAutomated Trading Signals & Superior Growth Investment - earlytimes.in
Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 5%Here's What Happened - MarketBeat
Collegium Announces the Closing of $980 Million Syndicated Credit Facility - The Globe and Mail
Liquidity Mapping Around (COLL) Price Events - Stock Traders Daily
Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Collegium Pharmaceutical Inc Azioni (COLL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Dreyer Scott | EVP & Chief Commercial Officer |
Dec 08 '25 |
Option Exercise |
15.90 |
17,600 |
279,840 |
121,213 |
| Dreyer Scott | EVP & Chief Commercial Officer |
Dec 08 '25 |
Sale |
48.17 |
17,600 |
847,855 |
103,613 |
| Balice-Gordon Rita J. | Director |
Dec 05 '25 |
Sale |
47.03 |
3,650 |
171,673 |
52,629 |
3.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):